{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:24:41Z","timestamp":1768400681788,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23792010"],"award-info":[{"award-number":["23792010"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.exer.2012.02.015","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T07:11:42Z","timestamp":1331277102000},"page":"98-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Anti-inflammatory effect of IL-6 receptor blockade in corneal alkali burn"],"prefix":"10.1016","volume":"97","author":[{"given":"Tohru","family":"Sakimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.exer.2012.02.015_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/ijc.22006","article-title":"Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas","volume":"119","author":"Adachi","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.exer.2012.02.015_bib2","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization","volume":"39","author":"Amano","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2012.02.015_bib3","doi-asserted-by":"crossref","first-page":"L199","DOI":"10.1152\/ajplung.00230.2006","article-title":"Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle","volume":"292","author":"Ammit","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"3","key":"10.1016\/j.exer.2012.02.015_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10384-010-0801-5","article-title":"Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis","volume":"54","author":"Chang","year":"2010","journal-title":"Jpn. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2012.02.015_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00003226-200007000-00025","article-title":"Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization","volume":"19","author":"Cursiefen","year":"2000","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.exer.2012.02.015_bib6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"issue":"21","key":"10.1016\/j.exer.2012.02.015_bib7","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/sj.onc.1208469","article-title":"Stat3 regulates genes common to both wound healing and cancer","volume":"24","author":"Dauer","year":"2005","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.exer.2012.02.015_bib8","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1167\/iovs.05-1651","article-title":"Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors","volume":"47","author":"Ebrahem","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2012.02.015_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2010.04.009","article-title":"Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses","volume":"91","author":"Hohki","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.exer.2012.02.015_bib10","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2353\/ajpath.2007.061018","article-title":"Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization","volume":"170","author":"Izumi-Nagai","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.exer.2012.02.015_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fj.99-1003rev","article-title":"The soluble interleukin 6 receptor: mechanisms of production and implications in disease","volume":"15","author":"Jones","year":"2001","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.exer.2012.02.015_bib12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/01.ico.0000214216.75496.7e","article-title":"Mooren ulcer: an immunopathologic study","volume":"25","author":"Kafkala","year":"2006","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.exer.2012.02.015_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0167-4889(02)00325-7","article-title":"The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases","volume":"1592","author":"Kallen","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.exer.2012.02.015_bib14","first-page":"1","article-title":"IL-6 signal transduction and its physiological roles: the signal orchestration model","volume":"149","author":"Kamimura","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"5082","key":"10.1016\/j.exer.2012.02.015_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1411569","article-title":"Interleukin-6 and its receptor: a paradigm for cytokines","volume":"258","author":"Kishimoto","year":"1992","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.exer.2012.02.015_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/intimm\/dxq030","article-title":"IL-6: from its discovery to clinical applications","volume":"22","author":"Kishimoto","year":"2010","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.exer.2012.02.015_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/cvr\/cvq078","article-title":"Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice","volume":"87","author":"Kobara","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.exer.2012.02.015_bib18","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.0801217","article-title":"Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6\/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model","volume":"184","author":"Matsumoto","year":"2010","journal-title":"J.\u00a0Immunol."},{"issue":"11","key":"10.1016\/j.exer.2012.02.015_bib19","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119821","article-title":"Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha","volume":"100","author":"Modur","year":"1997","journal-title":"J.\u00a0Clin. Invest."},{"issue":"4","key":"10.1016\/j.exer.2012.02.015_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/bjo.2004.052688","article-title":"Incidence of keratitis of varying severity among contact lens wearers","volume":"89","author":"Morgan","year":"2005","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2012.02.015_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.expneurol.2010.04.020","article-title":"Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation","volume":"224","author":"Mukaino","year":"2010","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.exer.2012.02.015_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9440(10)63312-3","article-title":"Interleukin-6\/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line","volume":"165","author":"Nakanishi","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.exer.2012.02.015_bib23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/archopht.1992.01080210110036","article-title":"Interleukin 6 facilitates corneal epithelial wound closure in\u00a0vivo","volume":"110","author":"Nishida","year":"1992","journal-title":"Arch. Ophthalmol."},{"issue":"13","key":"10.1016\/j.exer.2012.02.015_bib24","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.exer.2012.02.015_bib25","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.183.4.1399","article-title":"The function of the soluble interleukin 6 (IL-6) receptor in\u00a0vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6","volume":"183","author":"Peters","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"issue":"5","key":"10.1016\/j.exer.2012.02.015_bib26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00003226-200009000-00009","article-title":"The diagnosis and management of dry eye: a twenty-five-year review","volume":"19","author":"Pflugfelder","year":"2000","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.exer.2012.02.015_bib27","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.exer.2012.02.015_bib28","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9440(10)62357-7","article-title":"Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice","volume":"166","author":"Saika","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.exer.2012.02.015_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10384-008-0536-8","article-title":"Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing","volume":"52","author":"Sakimoto","year":"2008","journal-title":"Jpn. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2012.02.015_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-3083.2006.01750.x","article-title":"Interleukin-6 trans-signalling in chronic inflammation and cancer","volume":"63","author":"Scheller","year":"2006","journal-title":"Scand. J. Immunol."},{"issue":"3","key":"10.1016\/j.exer.2012.02.015_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10384-011-0002-x","article-title":"Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface","volume":"55","author":"Sugaya","year":"2011","journal-title":"Jpn. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2012.02.015_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00296-009-0953-0","article-title":"Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule","volume":"30","author":"Suzuki","year":"2010","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.exer.2012.02.015_bib33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1248\/bpb.31.1159","article-title":"Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis","volume":"31","author":"Uchiyama","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.exer.2012.02.015_bib34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yjmcc.2006.12.004","article-title":"Anti-rat soluble IL-6 receptor antibody down-regulates cardiac IL-6 and improves cardiac function following trauma-hemorrhage","volume":"42","author":"Yang","year":"2007","journal-title":"J.\u00a0Mol. Cell. Cardiol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351200084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351200084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:54:47Z","timestamp":1757998487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448351200084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S001448351200084X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2012.02.015","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory effect of IL-6 receptor blockade in corneal alkali burn","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2012.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}